gip/glp-1 drugs GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Understanding GIP & GLP-1 Medications

Improvement of glutathione production by metabolic engineering the sulfate assimilation pathway of Saccharomyces cerevisiae

Research indicates that reducing NNMT activity with 5-amino-1MQ alters metabolic processes, promotes changes in adipocyte function, and modulates muscle and nerve physiology

Timetemperaturetransformation (TTT) diagram of battery-grade Li-garnet electrolytes for low-temperature sustainable synthesis

Actionable Insight: Instead of booking a potentially unnecessary clinic appointment for 50, your first step should be to confirm your B12 status

10.1007/s13679-020-00375-0 56 TurckD.BressonJ.BurlingameB.DeanT.FairweatherTaitS.HeinonenM.et al (2017)